Simaravibart
Simaravibart (MAD-0004J08) is an IgG1κ antibody targeting the SARS-CoV2 spike (S) glycoprotein receptor binding domain[1].
Product Specifications
CAS Number
2657609-23-7
Product Name Alternative
MAD-0004J08
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/simaravibart.html
Purity
98.59
Solubility
10 mM in DMSO
Smiles
[Simaravibart]
Molecular Weight
(144.955 kDa)
References & Citations
[1]Lim SP. Targeting SARS-CoV-2 and host cell receptor interactions. Antiviral Res. 2023 Feb;210:105514.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY403937 100 µg
GRASP1 (GRIPAP1) (NM_207672) Human Over-expression Lysate
Sign In for Pricing
View Details